Description
Effective Treatment for Chronic Obstructive Pulmonary Disease (COPD) and Asthma
Breo Ellipta Inhaler is an inhaled medication used for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. It combines two powerful medications: Fluticasone furoate (a corticosteroid) and Vilanterol (a long-acting beta-agonist), to help open the airways and reduce inflammation, improving breathing and preventing flare-ups.
Breo Ellipta is available in 100 mcg/25 mcg and 200 mcg/25 mcg doses, offering flexibility for tailored treatment based on the severity of the condition.
Why Choose Breo Ellipta?
Dual Action: Combines an inhaled corticosteroid and long-acting bronchodilator for effective asthma and COPD management.
Convenient Once-Daily Use: Only one inhalation per day, making it easier for patients to stick to their treatment regimen.
Proven Efficacy: Reduces inflammation and improves airflow, preventing asthma and COPD exacerbations.
Available in Different Dosages: 100 mcg/25 mcg and 200 mcg/25 mcg for personalized treatment.
Common Usage & Dosage
Breo Ellipta is typically taken once a day as a single inhalation. The appropriate dosage is determined by your healthcare provider, depending on your medical condition and response to treatment. It is available in 100 mcg/25 mcg and 200 mcg/25 mcg dosages.
Reviews
There are no reviews yet.